Please login to the form below

Not currently logged in
Email:
Password:

Theresa May

This page shows the latest Theresa May news and features for those working in and with pharma, biotech and healthcare.

May’s Brexit plan cautiously welcomed by biopharma sector

May’s Brexit plan cautiously welcomed by biopharma sector

May’ s Brexit plan cautiously welcomed by biopharma sector. The white paper says the UK should adhere to EMA regulations post-Brexit. ... It split the Conservative party and been poo-pooed by President Trump, but Theresa May’s latest Brexit white

Latest news

More from news
Approximately 2 fully matching, plus 35 partially matching documents found.

Latest Intelligence

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    NHS England’s chief executive Simon Stevens (pictured opposite middle) is taking growing control of its future direction - and he has vocally called for more funding from Theresa May’s government. ... Most crucial of all is the long-term funding

  • Brexit Means Brexit Brexit Means Brexit

    Brexit Means Brexit. The differential destinations of post-Brexit pharma. “Brexit means Brexit.”The three little words that launched Theresa May’s leadership campaign in the aftermath of the EU referendum ... Thankfully, they reflect the position

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    Standing on the steps of Downing Street in April, Theresa May called on the country to give her a decisive mandate to deliver her vision for a post-EU future. ... There are five overarching issues to be aware of:. Theresa May’s political authority has

  • Truthful consumerism Truthful consumerism

    Trump pulls out of the Paris climate agreement. UK Prime Minister Theresa May calls a snap general election, seeking a mandate for Brexit strategy.

  • Shoring up the framework Shoring up the framework

    release. Marketing authorisation holders may be required to adapt their processes and even consider changes to the terms of their marketing authorisations for ‘continuous validity and exploitation’post-Brexit. ... Meanwhile, PME goes to press the day

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Social Media and Health: the Cure or the Disease?

    The Great Game that Russia is playing in the 21st century is heavily reliant on propaganda, according to Theresa May, who accused Putin of 'weaponising information'.(5). ... 5. Theresa May accuses Russia's President Putin of 'planting fake news' in a bid

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics